nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—SLC32A1—forebrain—attention deficit hyperactivity disorder	0.0135	0.0288	CbGeAlD
Glycine—GCSH—forebrain—attention deficit hyperactivity disorder	0.0106	0.0227	CbGeAlD
Glycine—SLC6A5—nervous system—attention deficit hyperactivity disorder	0.00936	0.0199	CbGeAlD
Glycine—SLC6A5—central nervous system—attention deficit hyperactivity disorder	0.00901	0.0192	CbGeAlD
Glycine—SLC6A9—midbrain—attention deficit hyperactivity disorder	0.00863	0.0184	CbGeAlD
Glycine—GLYATL2—nervous system—attention deficit hyperactivity disorder	0.00796	0.0169	CbGeAlD
Glycine—GLYATL2—central nervous system—attention deficit hyperactivity disorder	0.00766	0.0163	CbGeAlD
Glycine—SLC32A1—nervous system—attention deficit hyperactivity disorder	0.00734	0.0156	CbGeAlD
Glycine—SLC6A5—brain—attention deficit hyperactivity disorder	0.00715	0.0152	CbGeAlD
Glycine—SLC6A9—nervous system—attention deficit hyperactivity disorder	0.00709	0.0151	CbGeAlD
Glycine—GLRA3—nervous system—attention deficit hyperactivity disorder	0.00709	0.0151	CbGeAlD
Glycine—SLC32A1—central nervous system—attention deficit hyperactivity disorder	0.00707	0.0151	CbGeAlD
Glycine—ALAS1—forebrain—attention deficit hyperactivity disorder	0.007	0.0149	CbGeAlD
Glycine—SLC32A1—cerebellum—attention deficit hyperactivity disorder	0.00691	0.0147	CbGeAlD
Glycine—SLC6A9—central nervous system—attention deficit hyperactivity disorder	0.00683	0.0145	CbGeAlD
Glycine—GLRA3—central nervous system—attention deficit hyperactivity disorder	0.00683	0.0145	CbGeAlD
Glycine—GARS—forebrain—attention deficit hyperactivity disorder	0.00638	0.0136	CbGeAlD
Glycine—GRIN2C—forebrain—attention deficit hyperactivity disorder	0.00628	0.0134	CbGeAlD
Glycine—GLYATL2—brain—attention deficit hyperactivity disorder	0.00608	0.0129	CbGeAlD
Glycine—GATM—forebrain—attention deficit hyperactivity disorder	0.00606	0.0129	CbGeAlD
Glycine—GLRA1—nervous system—attention deficit hyperactivity disorder	0.00603	0.0128	CbGeAlD
Glycine—ALAS1—cardiovascular system—attention deficit hyperactivity disorder	0.00592	0.0126	CbGeAlD
Glycine—GLDC—midbrain—attention deficit hyperactivity disorder	0.00583	0.0124	CbGeAlD
Glycine—GLRA1—central nervous system—attention deficit hyperactivity disorder	0.00581	0.0124	CbGeAlD
Glycine—GCSH—nervous system—attention deficit hyperactivity disorder	0.00578	0.0123	CbGeAlD
Glycine—AGXT—cerebellum—attention deficit hyperactivity disorder	0.00567	0.0121	CbGeAlD
Glycine—SLC32A1—brain—attention deficit hyperactivity disorder	0.00561	0.012	CbGeAlD
Glycine—GCSH—central nervous system—attention deficit hyperactivity disorder	0.00557	0.0119	CbGeAlD
Glycine—GCSH—cerebellum—attention deficit hyperactivity disorder	0.00544	0.0116	CbGeAlD
Glycine—PIPOX—midbrain—attention deficit hyperactivity disorder	0.00544	0.0116	CbGeAlD
Glycine—SLC6A9—brain—attention deficit hyperactivity disorder	0.00542	0.0115	CbGeAlD
Glycine—GLRA3—brain—attention deficit hyperactivity disorder	0.00542	0.0115	CbGeAlD
Glycine—GARS—cardiovascular system—attention deficit hyperactivity disorder	0.00539	0.0115	CbGeAlD
Glycine—GCAT—midbrain—attention deficit hyperactivity disorder	0.00528	0.0112	CbGeAlD
Glycine—GLRB—forebrain—attention deficit hyperactivity disorder	0.0052	0.0111	CbGeAlD
Glycine—GLRA2—nervous system—attention deficit hyperactivity disorder	0.00492	0.0105	CbGeAlD
Glycine—GLDC—nervous system—attention deficit hyperactivity disorder	0.00479	0.0102	CbGeAlD
Glycine—GLRA2—central nervous system—attention deficit hyperactivity disorder	0.00473	0.0101	CbGeAlD
Glycine—SHMT2—cardiovascular system—attention deficit hyperactivity disorder	0.00469	0.00999	CbGeAlD
Glycine—GLRA2—cerebellum—attention deficit hyperactivity disorder	0.00463	0.00985	CbGeAlD
Glycine—ALAS1—midbrain—attention deficit hyperactivity disorder	0.00463	0.00985	CbGeAlD
Glycine—GLDC—central nervous system—attention deficit hyperactivity disorder	0.00461	0.00982	CbGeAlD
Glycine—GLDC—cerebellum—attention deficit hyperactivity disorder	0.00451	0.0096	CbGeAlD
Glycine—PIPOX—nervous system—attention deficit hyperactivity disorder	0.00447	0.00952	CbGeAlD
Glycine—GCSH—brain—attention deficit hyperactivity disorder	0.00442	0.00941	CbGeAlD
Glycine—GLRB—cardiovascular system—attention deficit hyperactivity disorder	0.0044	0.00936	CbGeAlD
Glycine—GCAT—nervous system—attention deficit hyperactivity disorder	0.00434	0.00924	CbGeAlD
Glycine—GRIN2A—forebrain—attention deficit hyperactivity disorder	0.00434	0.00923	CbGeAlD
Glycine—PIPOX—central nervous system—attention deficit hyperactivity disorder	0.00431	0.00917	CbGeAlD
Glycine—GARS—midbrain—attention deficit hyperactivity disorder	0.00421	0.00897	CbGeAlD
Glycine—PIPOX—cerebellum—attention deficit hyperactivity disorder	0.00421	0.00896	CbGeAlD
Glycine—GCAT—central nervous system—attention deficit hyperactivity disorder	0.00418	0.00889	CbGeAlD
Glycine—GCAT—cerebellum—attention deficit hyperactivity disorder	0.00408	0.00869	CbGeAlD
Glycine—GATM—midbrain—attention deficit hyperactivity disorder	0.004	0.00852	CbGeAlD
Glycine—GNMT—brain—attention deficit hyperactivity disorder	0.00386	0.00822	CbGeAlD
Glycine—ALAS1—nervous system—attention deficit hyperactivity disorder	0.0038	0.0081	CbGeAlD
Glycine—GSS—forebrain—attention deficit hyperactivity disorder	0.00379	0.00808	CbGeAlD
Glycine—GLRA2—brain—attention deficit hyperactivity disorder	0.00376	0.008	CbGeAlD
Glycine—SHMT2—midbrain—attention deficit hyperactivity disorder	0.00367	0.0078	CbGeAlD
Glycine—GLDC—brain—attention deficit hyperactivity disorder	0.00366	0.0078	CbGeAlD
Glycine—ALAS1—central nervous system—attention deficit hyperactivity disorder	0.00366	0.0078	CbGeAlD
Glycine—ALAS1—cerebellum—attention deficit hyperactivity disorder	0.00358	0.00762	CbGeAlD
Glycine—GARS—nervous system—attention deficit hyperactivity disorder	0.00346	0.00737	CbGeAlD
Glycine—GLRB—midbrain—attention deficit hyperactivity disorder	0.00343	0.00731	CbGeAlD
Glycine—PIPOX—brain—attention deficit hyperactivity disorder	0.00342	0.00728	CbGeAlD
Glycine—GRIN2C—nervous system—attention deficit hyperactivity disorder	0.00341	0.00725	CbGeAlD
Glycine—GARS—central nervous system—attention deficit hyperactivity disorder	0.00333	0.0071	CbGeAlD
Glycine—GCAT—brain—attention deficit hyperactivity disorder	0.00332	0.00706	CbGeAlD
Glycine—GATM—nervous system—attention deficit hyperactivity disorder	0.00329	0.007	CbGeAlD
Glycine—GRIN2C—central nervous system—attention deficit hyperactivity disorder	0.00328	0.00698	CbGeAlD
Glycine—GARS—cerebellum—attention deficit hyperactivity disorder	0.00326	0.00694	CbGeAlD
Glycine—GSS—cardiovascular system—attention deficit hyperactivity disorder	0.00321	0.00683	CbGeAlD
Glycine—GRIN2C—cerebellum—attention deficit hyperactivity disorder	0.00321	0.00683	CbGeAlD
Glycine—GATM—central nervous system—attention deficit hyperactivity disorder	0.00317	0.00674	CbGeAlD
Glycine—GATM—cerebellum—attention deficit hyperactivity disorder	0.00309	0.00659	CbGeAlD
Glycine—SHMT2—nervous system—attention deficit hyperactivity disorder	0.00301	0.00642	CbGeAlD
Glycine—ALAS1—brain—attention deficit hyperactivity disorder	0.00291	0.00619	CbGeAlD
Glycine—SHMT2—central nervous system—attention deficit hyperactivity disorder	0.0029	0.00618	CbGeAlD
Glycine—GRIN2A—midbrain—attention deficit hyperactivity disorder	0.00286	0.0061	CbGeAlD
Glycine—SHMT2—cerebellum—attention deficit hyperactivity disorder	0.00284	0.00604	CbGeAlD
Glycine—GLRB—nervous system—attention deficit hyperactivity disorder	0.00282	0.00601	CbGeAlD
Glycine—SHMT1—nervous system—attention deficit hyperactivity disorder	0.00274	0.00584	CbGeAlD
Glycine—GLRB—central nervous system—attention deficit hyperactivity disorder	0.00272	0.00579	CbGeAlD
Glycine—GLRB—cerebellum—attention deficit hyperactivity disorder	0.00266	0.00566	CbGeAlD
Glycine—GARS—brain—attention deficit hyperactivity disorder	0.00265	0.00564	CbGeAlD
Glycine—SHMT1—central nervous system—attention deficit hyperactivity disorder	0.00264	0.00562	CbGeAlD
Glycine—GRIN2C—brain—attention deficit hyperactivity disorder	0.0026	0.00555	CbGeAlD
Glycine—SHMT1—cerebellum—attention deficit hyperactivity disorder	0.00258	0.0055	CbGeAlD
Glycine—GATM—brain—attention deficit hyperactivity disorder	0.00251	0.00535	CbGeAlD
Glycine—GSS—midbrain—attention deficit hyperactivity disorder	0.00251	0.00533	CbGeAlD
Glycine—GRIN2A—nervous system—attention deficit hyperactivity disorder	0.00235	0.00501	CbGeAlD
Glycine—SLC36A1—nervous system—attention deficit hyperactivity disorder	0.00234	0.00498	CbGeAlD
Glycine—SHMT2—brain—attention deficit hyperactivity disorder	0.0023	0.0049	CbGeAlD
Glycine—GRIN2A—central nervous system—attention deficit hyperactivity disorder	0.00227	0.00483	CbGeAlD
Glycine—SLC36A1—central nervous system—attention deficit hyperactivity disorder	0.00225	0.0048	CbGeAlD
Glycine—GRIN2A—cerebellum—attention deficit hyperactivity disorder	0.00222	0.00472	CbGeAlD
Glycine—SLC36A1—cerebellum—attention deficit hyperactivity disorder	0.0022	0.00469	CbGeAlD
Glycine—GLRB—brain—attention deficit hyperactivity disorder	0.00216	0.00459	CbGeAlD
Glycine—SHMT1—brain—attention deficit hyperactivity disorder	0.0021	0.00446	CbGeAlD
Glycine—GSS—nervous system—attention deficit hyperactivity disorder	0.00206	0.00439	CbGeAlD
Glycine—GSS—central nervous system—attention deficit hyperactivity disorder	0.00198	0.00422	CbGeAlD
Glycine—GSS—cerebellum—attention deficit hyperactivity disorder	0.00194	0.00413	CbGeAlD
Glycine—GRIN2A—brain—attention deficit hyperactivity disorder	0.0018	0.00383	CbGeAlD
Glycine—SLC36A1—brain—attention deficit hyperactivity disorder	0.00179	0.00381	CbGeAlD
Glycine—GSS—brain—attention deficit hyperactivity disorder	0.00157	0.00335	CbGeAlD
Glycine—GRIN2A—Alzheimers Disease—CACNA1C—attention deficit hyperactivity disorder	0.00156	0.00295	CbGpPWpGaD
Glycine—GLYATL1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00156	0.00294	CbGpPWpGaD
Glycine—GLYAT—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00156	0.00294	CbGpPWpGaD
Glycine—GLYATL2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00156	0.00294	CbGpPWpGaD
Glycine—GLYATL2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00155	0.00292	CbGpPWpGaD
Glycine—GLYAT—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00155	0.00292	CbGpPWpGaD
Glycine—GLYATL1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00155	0.00292	CbGpPWpGaD
Glycine—GSS—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00154	0.00291	CbGpPWpGaD
Glycine—GPR18—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00154	0.0029	CbGpPWpGaD
Glycine—GPR18—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00152	0.00287	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00151	0.00285	CbGpPWpGaD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0015	0.00283	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00149	0.00282	CbGpPWpGaD
Glycine—SLC6A5—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00149	0.00281	CbGpPWpGaD
Glycine—SLC6A9—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00149	0.00281	CbGpPWpGaD
Glycine—BAAT—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00148	0.00279	CbGpPWpGaD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00145	0.00274	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00145	0.00273	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00144	0.00271	CbGpPWpGaD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00143	0.00269	CbGpPWpGaD
Glycine—SHMT1—Amino acid and derivative metabolism—TPH2—attention deficit hyperactivity disorder	0.00142	0.00269	CbGpPWpGaD
Glycine—SLC16A10—cerebellum—attention deficit hyperactivity disorder	0.00142	0.00302	CbGeAlD
Glycine—GPR18—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00142	0.00267	CbGpPWpGaD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00141	0.00266	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00138	0.00261	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00136	0.00256	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00134	0.00253	CbGpPWpGaD
Glycine—SLC32A1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00133	0.00251	CbGpPWpGaD
Glycine—SLC32A1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00132	0.00249	CbGpPWpGaD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00131	0.00248	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00129	0.00242	CbGpPWpGaD
Glycine—SLC16A10—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00127	0.0024	CbGpPWpGaD
Glycine—SLC32A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00127	0.00239	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00124	0.00235	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00122	0.00231	CbGpPWpGaD
Glycine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00122	0.00229	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00122	0.00229	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00121	0.00228	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0012	0.00227	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.0012	0.00226	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00119	0.00225	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00114	0.00215	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00113	0.00212	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00106	0.00201	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00106	0.002	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00105	0.00199	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00102	0.00192	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00101	0.00191	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00101	0.00191	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.001	0.00189	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000982	0.00185	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000979	0.00185	CbGpPWpGaD
Glycine—GARS—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000963	0.00182	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000948	0.00179	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000932	0.00176	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000929	0.00175	CbGpPWpGaD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00092	0.00174	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00092	0.00174	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000915	0.00173	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00091	0.00172	CbGpPWpGaD
Glycine—GSS—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000903	0.0017	CbGpPWpGaD
Glycine—GSS—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000897	0.00169	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000892	0.00168	CbGpPWpGaD
Glycine—GSS—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000891	0.00168	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000857	0.00162	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000851	0.0016	CbGpPWpGaD
Glycine—ALAS2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000849	0.0016	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000815	0.00154	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000812	0.00153	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000802	0.00151	CbGpPWpGaD
Glycine—ALAS1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000794	0.0015	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000788	0.00149	CbGpPWpGaD
Glycine—ALAS1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000777	0.00147	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000758	0.00143	CbGpPWpGaD
Glycine—SLC6A5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000758	0.00143	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000758	0.00143	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—EP300—attention deficit hyperactivity disorder	0.000741	0.0014	CbGpPWpGaD
Glycine—SLC36A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000728	0.00137	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000701	0.00132	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000698	0.00132	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000681	0.00128	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000652	0.00123	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000649	0.00122	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000646	0.00122	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000645	0.00122	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000644	0.00121	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000644	0.00121	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000644	0.00121	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000643	0.00121	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000643	0.00121	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000643	0.00121	CbGpPWpGaD
Glycine—GATM—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000643	0.00121	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00064	0.00121	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000626	0.00118	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000622	0.00117	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000618	0.00117	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000617	0.00116	CbGpPWpGaD
Glycine—BAAT—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000613	0.00116	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.0006	0.00113	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000595	0.00112	CbGpPWpGaD
Glycine—ALAS2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000586	0.0011	CbGpPWpGaD
Glycine—ALAS2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000586	0.0011	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000581	0.0011	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000579	0.00109	CbGpPWpGaD
Glycine—ALAS2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000576	0.00109	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000553	0.00104	CbGpPWpGaD
Glycine—AGXT—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000547	0.00103	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00054	0.00102	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000538	0.00101	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000536	0.00101	CbGpPWpGaD
Glycine—ALAS2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000536	0.00101	CbGpPWpGaD
Glycine—ALAS1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000536	0.00101	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000535	0.00101	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00053	0.000999	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000527	0.000993	CbGpPWpGaD
Glycine—SHMT1—Disease—STUB1—attention deficit hyperactivity disorder	0.000527	0.000993	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000527	0.000993	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000525	0.00099	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00052	0.000981	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000517	0.000974	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000502	0.000947	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000498	0.000938	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000494	0.000931	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000492	0.000928	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00049	0.000925	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000489	0.000921	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000486	0.000917	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000484	0.000914	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000478	0.000902	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000472	0.00089	CbGpPWpGaD
Glycine—ALAS2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000468	0.000883	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000465	0.000877	CbGpPWpGaD
Glycine—ALAS2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000446	0.000841	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000444	0.000837	CbGpPWpGaD
Glycine—GLYAT—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000444	0.000837	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000444	0.000837	CbGpPWpGaD
Glycine—GATM—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000444	0.000837	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000444	0.000837	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000444	0.000837	CbGpPWpGaD
Glycine—GATM—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000444	0.000837	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000444	0.000837	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000443	0.000836	CbGpPWpGaD
Glycine—SLC16A10—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000443	0.000834	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00044	0.00083	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000437	0.000823	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000437	0.000823	CbGpPWpGaD
Glycine—GLYAT—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000437	0.000823	CbGpPWpGaD
Glycine—GATM—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000437	0.000823	CbGpPWpGaD
Glycine—BAAT—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000423	0.000798	CbGpPWpGaD
Glycine—BAAT—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000423	0.000798	CbGpPWpGaD
Glycine—BAAT—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000417	0.000786	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000415	0.000783	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000406	0.000766	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000406	0.000766	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000406	0.000766	CbGpPWpGaD
Glycine—GATM—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000406	0.000766	CbGpPWpGaD
Glycine—BAAT—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000387	0.00073	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000379	0.000715	CbGpPWpGaD
Glycine—AGXT—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000377	0.000712	CbGpPWpGaD
Glycine—AGXT—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000377	0.000712	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000377	0.000711	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000374	0.000706	CbGpPWpGaD
Glycine—AGXT—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000371	0.0007	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00037	0.000698	CbGpPWpGaD
Glycine—GSS—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000369	0.000696	CbGpPWpGaD
Glycine—ALAS1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000366	0.000689	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000366	0.000689	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000365	0.000689	CbGpPWpGaD
Glycine—ALAS1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00036	0.000678	CbGpPWpGaD
Glycine—ALAS2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000355	0.000669	CbGpPWpGaD
Glycine—GATM—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000355	0.000669	CbGpPWpGaD
Glycine—GLYAT—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000355	0.000669	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000355	0.000669	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000355	0.000669	CbGpPWpGaD
Glycine—ALAS2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000352	0.000664	CbGpPWpGaD
Glycine—AGXT—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000345	0.000651	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000339	0.00064	CbGpPWpGaD
Glycine—BAAT—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000339	0.000638	CbGpPWpGaD
Glycine—GATM—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000338	0.000637	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000338	0.000637	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000338	0.000637	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000338	0.000637	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000334	0.00063	CbGpPWpGaD
Glycine—BAAT—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000322	0.000608	CbGpPWpGaD
Glycine—AGXT2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000321	0.000605	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000321	0.000605	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000319	0.000602	CbGpPWpGaD
Glycine—AGXT2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000316	0.000595	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000308	0.000581	CbGpPWpGaD
Glycine—AGXT—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000302	0.000569	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000297	0.00056	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000294	0.000553	CbGpPWpGaD
Glycine—ALAS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000292	0.000551	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000287	0.000542	CbGpPWpGaD
Glycine—AGXT—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000287	0.000542	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000282	0.000533	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000279	0.000526	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000278	0.000525	CbGpPWpGaD
Glycine—GATM—Metabolism—COMT—attention deficit hyperactivity disorder	0.000269	0.000507	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000269	0.000507	CbGpPWpGaD
Glycine—GLYAT—Metabolism—COMT—attention deficit hyperactivity disorder	0.000269	0.000507	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000269	0.000507	CbGpPWpGaD
Glycine—GLYAT—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000267	0.000504	CbGpPWpGaD
Glycine—GATM—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000267	0.000504	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000267	0.000504	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000267	0.000504	CbGpPWpGaD
Glycine—SHMT1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000262	0.000493	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000262	0.000493	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00026	0.00049	CbGpPWpGaD
Glycine—SHMT1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000257	0.000485	CbGpPWpGaD
Glycine—AGXT2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000257	0.000484	CbGpPWpGaD
Glycine—BAAT—Metabolism—COMT—attention deficit hyperactivity disorder	0.000257	0.000484	CbGpPWpGaD
Glycine—GSS—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000255	0.000481	CbGpPWpGaD
Glycine—GSS—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000255	0.000481	CbGpPWpGaD
Glycine—BAAT—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000255	0.00048	CbGpPWpGaD
Glycine—GSS—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000251	0.000473	CbGpPWpGaD
Glycine—SHMT1—Disease—SNAP25—attention deficit hyperactivity disorder	0.00025	0.000471	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000247	0.000466	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000244	0.000461	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000239	0.000451	CbGpPWpGaD
Glycine—GSS—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000233	0.00044	CbGpPWpGaD
Glycine—AGXT—Metabolism—COMT—attention deficit hyperactivity disorder	0.000229	0.000431	CbGpPWpGaD
Glycine—AGXT—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000227	0.000428	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000225	0.000424	CbGpPWpGaD
Glycine—ALAS1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000221	0.000418	CbGpPWpGaD
Glycine—ALAS1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00022	0.000415	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000213	0.000402	CbGpPWpGaD
Glycine—SHMT1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000209	0.000394	CbGpPWpGaD
Glycine—GSS—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000204	0.000384	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000199	0.000375	CbGpPWpGaD
Glycine—AGXT2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000194	0.000367	CbGpPWpGaD
Glycine—GSS—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000194	0.000366	CbGpPWpGaD
Glycine—AGXT2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000193	0.000364	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000182	0.000343	CbGpPWpGaD
Glycine—SHMT1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000159	0.000299	CbGpPWpGaD
Glycine—SHMT1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000157	0.000297	CbGpPWpGaD
Glycine—GSS—Metabolism—COMT—attention deficit hyperactivity disorder	0.000154	0.000291	CbGpPWpGaD
Glycine—GSS—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000153	0.000289	CbGpPWpGaD
Glycine—ALAS2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000152	0.000287	CbGpPWpGaD
Glycine—GLYAT—Metabolism—EP300—attention deficit hyperactivity disorder	0.000115	0.000217	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000115	0.000217	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000115	0.000217	CbGpPWpGaD
Glycine—GATM—Metabolism—EP300—attention deficit hyperactivity disorder	0.000115	0.000217	CbGpPWpGaD
Glycine—BAAT—Metabolism—EP300—attention deficit hyperactivity disorder	0.00011	0.000207	CbGpPWpGaD
Glycine—AGXT—Metabolism—EP300—attention deficit hyperactivity disorder	9.81e-05	0.000185	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.64e-05	0.000182	CbGpPWpGaD
Glycine—ALAS1—Metabolism—EP300—attention deficit hyperactivity disorder	9.5e-05	0.000179	CbGpPWpGaD
Glycine—AGXT2—Metabolism—EP300—attention deficit hyperactivity disorder	8.34e-05	0.000157	CbGpPWpGaD
Glycine—SHMT1—Disease—EP300—attention deficit hyperactivity disorder	8.12e-05	0.000153	CbGpPWpGaD
Glycine—SHMT1—Metabolism—EP300—attention deficit hyperactivity disorder	6.8e-05	0.000128	CbGpPWpGaD
Glycine—GSS—Metabolism—EP300—attention deficit hyperactivity disorder	6.62e-05	0.000125	CbGpPWpGaD
